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Integrin 31 (CD 49c/29) Is a Cellular Receptor
for Kaposi’s Sarcoma-Associated Herpesvirus
(KSHV/HHV-8) Entry into the Target Cells
velope-associated HHV-8 glycoprotein gB(ORF8) and
gpK8.1A with HS molecules (Akula et al., 2001a; Wang
et al., 2001).
HHV-8 gB ORF consists of 845 amino acids, and
among the , , and  herpesvirus gB sequenced to
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Kansas City, Kansas 66160 date, only HHV-8 gB possesses the RGD (Arg-Gly-Asp)
amino acids (aa 27–29) at the extracellular amino termi-
nus coil region after the putative signal sequence (Russo
et al., 1996). Sequence analyses of 63 HHV-8 strainsSummary
from different geographical locations show that the gB-
RGD sequence is highly conserved (Meng et al., 1999).Human herpesvirus-8 (HHV-8) is implicated in the
pathogenesis of Kaposi’s sarcoma. HHV-8 envelope The RGD amino acids are the minimal region of many
extracellular matrix (ECM) proteins required for the inter-glycoprotein B possesses the RGD motif known to
interact with integrin molecules, and HHV-8 infectivity actions with a subset of host cell surface integrins (Plow
et al., 2000). Integrins are a large family of heterodimericwas inhibited by RGD peptides, antibodies against
RGD-dependent 3 and 1 integrins, and by soluble receptors containing noncovalently-associated trans-
membrane  and  glycoprotein subunits (Giancotti and31 integrin. Expression of human 3 integrin in-
creased the infectivity of virus for Chinese hamster Ruoslahti, 1999). There are 17  and 8  subunits, and
each  combination has its own binding specificityovary cells. Anti-gB antibodies immunoprecipitated
the virus-3 and -1 complexes, and virus binding and signaling properties (Giancotti and Ruoslahti, 1999).
Nonenveloped viruses like adenoviruses (V3, V5,studies suggest a role for31 in HHV-8 entry. Further,
HHV-8 infection induced the integrin-mediated activa- and M2; Nemerow, 2000; Li et al., 2001), rotaviruses
(21, 41, and V3; Hewish et al., 2000; Guerrerotion of focal adhesion kinase (FAK). These findings
implicate a role for 31 integrin and the associated et al., 2000), human parechovirus 1 (V1 and V3;
Triantafilou et al., 2000), and enveloped hantavirus (3;signaling pathways in HHV-8 entry into the target cells.
Gavrilovskaya et al., 1998) have been reported to use
one or more integrin molecules during the infectiousIntroduction
process. To date, members of herpesviruses have not
been shown to interact with integrins.Kaposi’s sarcoma (KS) is associated with HIV-1 infec-
tion, and in the absence of HIV-1, KS occurs in three Since HHV-8 gB possesses the RGD sequence, the
role of integrins in the infectious process of HHV-8 wasepidemiologically distinct forms. Kaposi’s sarcoma-
associated herpesvirus (KSHV) or HHV-8 DNA was de- investigated. In this study, we provide several lines of
evidence that implicate the RGD binding 31 (CD49c/tected in all epidemiological forms of KS, and several
studies suggest a potential role of HHV-8 in KS patho- 29) integrin molecule as one of the in vitro cellular recep-
tors involved in HHV-8’s entry into the target cells.genesis (Antman and Chang, 2000). Cell lines with B cell
characteristics established from the body cavity-based
B cell lymphomas (BCBL) carry HHV-8 in a latent form, Results
and a lytic cycle can be induced by 12-O-tetradeca-
noylphorbol-13-acetate (TPA) (Schulz et al., 1998). Peptides with RGD Amino Acids Inhibit
HHV-8 DNA and transcripts have been identified in HHV-8 Infection
vivo in human B cells, endothelial cells, epithelial cells, To monitor the HHV-8 binding and entry process, HFF,
keratinocytes, and macrophages (Antman and Chang, adult human dermal microvascular endothelial cells
2000). HHV-8 has been shown to infect human B, epithe- (HMVEC-d), and a recombinant GFP-HHV-8 expressing
lial, endothelial, and foreskin fibroblast (HFF) cells and GFP under the elongation factor-1--promoter control
keratinocytes (Renne et al., 1998; Cerimele et al., 2001; were used (Vieira et al., 2001). Since only a latent HHV-8
Vieira et al., 2001). However, analysis of HHV-8 infection infection was observed in these cells, GFP expression
is hampered by the absence of a lytic replication cycle represents the input virus entry and infection and not a
and a reliable plaque assay. In addition, infection is often reinfection from lytic replication. The entry and infection
latent, as evidenced by the presence of circular latent of cells were monitored by counting the number of green
HHV-8 DNA and by the expression of HHV-8 latency- fluorescent cells (Figures 1A–1C) and confirmed by the
associated nuclear antigen encoded by the open read- detection of ORF73 protein (Figures 1D–1F).
ing frame (ORF) 73 (Vieira et al., 2001). The broad in Since HHV-8 gB possesses the RGD sequence, syn-
vitro cellular tropism of HHV-8 may be in part due to thetic peptides with and without RGD sequences were
its interaction with the ubiquitous cell surface heparin incubated with HFF cells for 1 hr at 4C before GFP-
sulfate (HS)-like molecule (Akula et al., 2001b). HHV-8 HHV-8 infection. HHV-8 infectivity was significantly (p 
encodes for several glycoproteins (Russo et al., 1996), 0.05; chi-square test) inhibited by the RGD peptides
and we have demonstrated the interaction of virion en- (RGD, GRGDTP) and by the RGD-containing gB peptide
(RGDgBN-1; RGDTFQTSSSPTPPGSSS) at 1.5 mM and
15 mM concentrations and not by the GRGESP peptide1 Correspondence: bchandra@kumc.edu
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Figure 1. Measurement of GFP-HHV-8 Infectivity
HFF cells treated with DMEM (A, B, D and E) or with DMEM containing 1.5 mM of GRGDTP peptide (C and F) for 1 hr at 4C were either mock
infected (A and D) or infected with GFP-HHV-8 (B, C, E, and F) at 37C for 2 hr, washed, and incubated at 37C for 3 days with growth medium.
Green fluorescent cells indicative of GFP-HHV-8 entry and infection were counted (A, B, and C). Approximately 190 green fluorescent cells
per well were detected after infection with 100 l of GFP-HHV-8. Cells were fixed with acetone and reacted with MAb against HHV-8 ORF73
protein, biotinylated anti-mouse antibodies, and substrate (D, E, and F). Arrows indicate nuclei of cells expressing the ORF 73 protein
(magnification 400).
(Figure 2A). Even though the inhibition observed with gions probably have contributed to the higher percent-
age of inhibition by the anti-gB antibodies. Nevertheless,15 mM of RGDgBN-1 peptide was significantly higher
than the GRGESP control peptide, it was lower than the inhibition by anti-RGDgB-N1 antibodies suggests a role
for HHV-8 gB RGD motif in the interaction with the targetinhibition observed with the GRGDTP and RGD pep-
tides. This could be due to aggregation of the 18-aa- cells, potentially with integrins.
long RGDgBN-1 peptide at higher concentrations more
than the shorter RGD and GRGDTP peptides. GFP- Inhibition of HHV-8 Infection by Integrin Ligands
To determine the role of integrins in HHV-8 infection,HHV-8 used here is not clonal and contains both wild-
type and recombinant viruses. Nevertheless, when vi- HFF cells were incubated with ECM proteins before
GFP-HHV-8 infection. Fibronectin (FN), known to inter-rus-infected cells were monitored for the ORF 73 protein
expression (Figures 1D–1F), inhibition comparable to act with integrins by RGD-dependent and -independent
mechanisms, inhibited HHV-8 infectivity by 50%  3%GFP expression inhibition was observed with the RGD-
containing peptides (data not shown). Inhibition by the at 50 g/ml concentrations (Figure 2C), and inhibition
did not increase significantly at 80g/ml concentrationsRGD peptides suggests a potential RGD-dependent
HHV-8 interaction with the host cell surface and, hence, (data not shown). When cells were incubated with 25
and 50 g/ml of laminin, also known to bind integrinsa role for integrins in the biology of HHV-8.
by RGD-dependent and -independent mechanisms, a
moderate but significant (p  0.05; chi-square test) in-Antibodies to Peptides Containing RGD Amino
Acids Inhibit HHV-8 Infection crease in GFP-HHV-8 infectivity was observed (Figure
2C). The reason for this increased infection is underRabbit antibodies directed against the RGD-containing
peptide (RGDgB-N1) significantly inhibited the GFP- further investigation. In contrast, collagen type I, tenas-
cin, vitronectin, BSA, and chondroitin sulfate A and CHHV-8 infection (p  0.05; chi-square test) in a dose-
dependent manner (Figure 2B). In contrast, rabbit anti- had no significant effect on GFP-HHV-8 infectivity (Fig-
ure 2C). These results also suggested a possible role ofbodies against peptides lacking the RGD motif (gB-N2-
GVENTFTDRDDVNTTVFLQPVEGLT and gB-C-RGYKP integrins in HHV-8 infectivity.
LTQSLDISPETGE) did not show any significant inhibition
(Figure 2B). The 50% inhibition by anti-RGDgB-N1 anti- Antibodies to 3 and 1 Integrins Inhibit
HHV-8 Infectivitybodies at 30 g/ml concentration was comparable to
the inhibition by rabbit anti-gB IgG antibodies (Figure FN binds to 31, 51, 81, V1, V3, V5, V6,
and II3 integrins via the RGD sequence and to 21,2B), and antibodies against additional immunogenic re-
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41, 47, and V8 integrins in an RGD-independent
manner (Plow et al., 2000). Monoclonal antibodies
against the RGD binding 3 and 1 integrin subunits
inhibited HHV-8 infectivity by 48%  4% and 35% 
5%, respectively, in HFF cells (Figure 3A) and by 46% 
2% and 36%  3%, respectively, in HMVEC-d cells
(Figure 3A). The difference between the percentage inhi-
bition of HHV-8 infectivity by MAbs to 3 and 1 integrin
subunits was statistically significant (p  0.05). About
30%  5% of GFP-HHV-8 infectivity was also inhibited
by MAb against the RGD-independent 21 integrin, in
HFF and HMVEC-d cells (Figure 3A). However, there was
no significant difference between the inhibition by 1
and 21 MAbs, and the similarities in the inhibition
levels suggest that inhibition with anti-21 MAbs could
be due to crossreactivity with the 1 integrin subunit.
Similar isotype-specific antibodies against other RGD
and non-RGD binding (1, 6, V, 4, 51, V3, V5,
and V6) integrins did not show any significant inhibi-
tion of HHV-8 infectivity (Figure 3A), thus demonstrating
the specificity of inhibition by anti-3 and anti-1 anti-
bodies.
MAbs to3 and1 integrins inhibited HHV-8 infectivity
in a dose-dependent manner with an optimal antibody
concentration of about 2 g/ml (Figure 3B). When anti-
bodies against 3 and 1 subunits or antibodies against
21, 3, and 1 integrins were mixed and added to
the HFF cells prior to infection, there was no significant
additive effect of inhibition (Figure 3B). Incomplete inhi-
bition of HHV-8 infectivity by the anti-3 and anti-1
antibodies could be attributed to the nature of antibod-
ies and/or due to additional cell surface molecules rec-
ognized by HHV-8. Nevertheless, these results implicate
an involvement of 31 integrin in the infectious process
of HHV-8.
Soluble 31 Integrin Blocks HHV-8 Infection
The 3 integrin subunit is expressed on the cell surface
only in combination with the 1 integrin subunit (Plow
et al., 2000). Since 31 integrin binds FN via the RGD
sequence and since antibodies against 3 integrin sub-
unit neutralized infectivity better than other integrin anti-
bodies, we focused on the role of RGD-dependent 31
integrin in HHV-8 infectivity. Among the RGD binding
integrins, only the soluble 31 and 51 integrins were
commercially available in 10 mM octyl-b-D-glucopyra-
noside formulation. This formulation did not disrupt the
cell membranes and was not toxic at less than 20 g/
ml of soluble integrin. Soluble 31 blocked infection
significantly in a dose-dependent manner with about
75%  3% inhibition at 5 g/ml concentration (Figure
3C). The specificity of this reaction was demonstrated
Figure 2. RGD-Dependent HHV-8 Interactions with the Host Cell by the absence of inhibition by 51 integrin (Figure
Surface 3C). These results clearly suggest that 31 integrin
(A) Inhibition of GFP-HHV-8 infectivity by peptides with RGD amino plays a role in the infectious process of HHV-8.
acids. HFF cells were incubated with RGD, GRGDTP, GRGESP, and
RGDgBN-1 (RGDTFQTSSSPTPPGSSS) peptides in DMEM at 4C
for 1 hr, washed, and incubated with 100 l of GFP-HHV-8 at 37C
for 2 hr. (C) Inhibition of GFP-HHV-8 infectivity by integrin ligands. HFF cells
(B) Inhibition of GFP-HHV-8 infectivity by antibodies against HHV-8 were incubated with ECM proteins and glycoproteins at 4C for 1
gB peptide containing the RGD amino acids. GFP-HHV-8 (100 l) hr, washed, and infected with GFP-HHV-8. HHV-8 infectivity was
was incubated at 37C for 1 hr with DMEM alone or with DMEM measured as described in the Figure 1 legend. Data are presented
containing rabbit IgG antibodies against HHV-8 gB (anti-gB) or as percentage of inhibition of virus infectivity obtained when the
against HHV-8 gB peptides with (anti-RGDgB-N1) and without RGD cells were preincubated with DMEM only. Each reaction was done
amino acids (gB-N2 and gB-C) or preimmune IgG antibodies. HFF in duplicate, and each point represents the average  the SD of
cells were incubated with these mixtures at 37C for 2 hr. three experiments.
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Figure 3. 31 Integrin Plays a Role in the
Infectious Process of HHV-8
(A) Inhibition of GFP-HHV-8 infectivity by anti-
integrin antibodies. Monolayers of HFF and
HMVEC-d cells were incubated with 20 g/
ml of MAbs against integrins and integrin sub-
units for 1 hr at 4C, washed, and infected
with GFP-HHV-8.
(B) Dose-dependent inhibition of GFP-HHV-8
infectivity by antibodies to3 and 1 subunits
of integrins. HFF cells were incubated with
MAbs (IgG1 isotype) against 3, 1, V, and
21 integrins, alone or in combinations, for
1 hr at 4C, washed, and infected with GFP-
HHV-8.
(C) Inhibition of GFP-HHV-8 infectivity by sol-
uble 31 integrin. GFP-HHV-8 (100 l) was
incubated with soluble 31 and 51 integ-
rins at 37C for 1 hr and added to HFF cells.
After 2 hr at 37C, cells were washed and
incubated for 3 days with growth medium.
HHV-8 infectivity was measured as described
in Figure 1. Data are presented as percentage
of inhibition of virus infectivity obtained when
the cells were preincubated with DMEM as
control. Each reaction was done in duplicate,
and each point represents the average  the
SD of three experiments.
Expression of 31 Integrin in the In Vitro Target of BCBL-1, BJAB, 293, HFF, and HMVEC-d cells (Figure
4E). The 3 integrin is expressed in more than 90% ofCells of HHV-8
To determine the relative abundance of 31 integrin in BJAB, HFF, and HMVEC-d cells and at a higher level in
HFF cells compared to other cells tested (Figure 4E).the various target cells of HHV-8, flow cytometric analy-
sis with various anti-integrin antibodies was carried out.
We analyzed the percentage of fluorescent cells with a HHV-8 Infection of CHO-B2 Cells Is Promoted
by the Expression of Human 3 Integrinfluorescence intensity higher than the negative control,
and we analyzed the mean fluorescence intensity (MFI) HHV-8 binds and enters a variety of human (BCBL-1,
BJAB, Raji, 293, HFF, Hela, and endothelial), monkey(Figure 4). The 1 integrin is relatively expressed at a
higher level than other integrins and in more than 87% (Vero and CV-1), hamster (BHK-21 and CHO), and mouse
Integrin 31 as a KSHV/HHV-8 Entry Receptor
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Figure 4. Flow Cytometric Analysis of 31 Integrin Expression
Cells were incubated with MAbs against integrins followed by FITC-anti-mouse antibodies and examined by FACS. HFF cells were incubated
with FITC-goat anti-mouse IgG (A), anti-V3-MAb LM609 (B), anti-3-MAb ASC-6 (C), and anti-1-MAb 6S6 (D). The percentage of fluorescent
cells with a fluorescence intensity higher than the negative control (A) and the MFI as an indication of expression levels were measured. The
histograms display relative cell numbers as a function of relative fluorescence intensities. (E) Table showing percentage number of target
cells positive for different integrins with MFI values for the gated positive cells within parenthesis. ND indicates not done.
(L) cells, as shown by the detection of HHV-8 DNA, and 2), and ORF 73 protein expressions (Figure 5B, im-
ages 3 and 4) were measured. The efficiency of infectionlimited HHV-8 gene expression, and GFP expression
(Renne et al., 1998; Akula et al., 2001b; Vieira et al., in CHO-B2 cells was about 25-fold less than the HFF
and HMVEC-d cells. However, the expression of human2001). To verify the role of 31 in HHV-8 infectivity,
CHO-B2 cells expressing low levels of endogenous 3 3 integrin increased the susceptibility to HHV-8 infec-
tion, and CHO-B2-B3 and D5 cells were 2–3 times moreintegrin were transfected with human 3 integrin cDNA
(CHO-B2-clones B3 and D5; Wu et al., 1995). The human susceptible to GFP-HHV-8 infectivity than the parental
CHO-B2 cells (Figure 5C). The permissiveness of these3 integrin in transfected cells has been shown to form
heterodimeric complexes with hamster 1 and is ex- cells was also shown by the increased expression of
ORF 73 protein (Figure 5B). The increase in the level ofpressed on the plasma membranes, with B3 cells ex-
pressing four times more human 3/hamster 1 integrin HHV-8 infectivity was specifically blocked by the prein-
cubation of cells with 2 g/ml of anti-human 3 antibod-than the D5 cells (Wu et al., 1995). FACS analyses
showed the expression of human 3 integrin in 23% and ies, but not by the isotype-specific antibodies against
human 4 integrin (Figure 5C).95% of CHO-B2-D5 and B3 cells, respectively (Figure
5A, graphs 1 and 2). The MFI values for human3 integrin The increased infectivity in these cells could be due
to the ability of human 3/hamster 1 integrin to mimicin the D5 and B3 cells were 186 and 116, respectively,
and the MFI values for hamster 3 and 1 integrins in a conformation resembling human 31 integrin. How-
ever, similar to our previous observations (Akula et al.,CHO cells were 3 and 60, respectively (Weitzman et al.,
1995). 2001b), we observed that even though the radiolabeled
HHV-8 binding to CHO cells mediated by HS-like mole-CHO cells expressing human 3 integrins were in-
fected with GFP-HHV-8 and GFP (Figure 5B, images 1 cules was comparable to HFF and 293 cells, virus infec-
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Figure 5. Human 31 Integrin Expression Promotes HHV-8 Infection of CHO-B2 Cells
(A) Flow cytometric analysis of human 3 integrin expression in CHO-B2 cells. Cells were incubated with MAbs against human 3 integrin
molecules and examined by FACS. (1) CHO-B2 cells transfected with control pCDNA3 plasmid. (2 and 3) CHO-B2 clone D5 and B3 cells,
respectively, transfected with pCDNA3-human 3 integrin cDNA. The percentage of cells expressing 3 integrin on the surface is indicated.
(B) Infection of CHO-B2 cells by GFP-HHV-8. CHO-B2 cells transfected with human 3 integrin cDNA (CHO-B2 clone D5 [1 and 3] and CHO-
B2 clone B3 [2 and 4]) were infected with 100 l of GFP-HHV-8 for 3 days at 37C. (1 and 2) GFP expression in CHO-B2 cells. (3 and 4) ORF
73 protein expression in CHO-B2 cells (arrows) (magnification 400).
(C) Recombinant human 3 integrin promotes CHO-B2 cell infection of GFP-HHV-8. CHO-B2 cells transfected with pCDNA3 (CHO-B2/pCDNA)
and pCDNA3 containing human 3 integrin cDNA (CHO-B2 clone D5 and B3) were infected with GFP-HHV-8 for 2 hr at 37C. Cells were also
infected after preincubation for 1 hr at 4C with 2 g/ml of MAbs against human 3 integrin subunit or with similar isotype MAbs (IgG1) against
human 4 subunit. Infectivity was measured as described in Figure 1. After infection with 100 l of GFP-HHV-8, approximately 7–8 green
fluorescent CHO-B2/pCDNA cells per well were detected. This was considered as 100% infectivity for comparison with infection of human
3 integrin expressing CHO-B2-D5 and -B3 cells. Each reaction was done in duplicate, and each point represents the average  the SD of
three experiments.
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tivity in human 3 integrin-expressing CHO-B2 cells was HHV-8 Interacts with 31 Integrin at a Postcell
Attachment Step8-fold less than the infectivity in human cells. Only very
HHV-8 interacts with cell surface HS during the initiallow levels of hamster 1 (MFI value 60) and 3 (MFI
attachment stage of infection (Akula et al., 2001b). Tovalue 3) integrins were detected in CHO cells. This sug-
determine whether HHV-8 interaction with cell surfacegests that the efficiency of HHV-8 entry in CHO cells
3 and 1 integrins occurred during attachment or at amay be dependent upon the density of 31 integrin, as
postattachment step, HHV-8 binding inhibition experi-well as other putative HHV-8 receptor(s). Nevertheless,
ments with RGD peptides, antibodies to RGDgB-N1these results indicate that the augmented HHV-8 infec-
peptide, antibodies to 3 and 1 integrins, and solubletivity is due to the expression of human 3 integrin and
31 and 51 integrins were carried out. Similar toconfirm the role of 31 integrin in HHV-8 infectivity.
our previous findings (Akula et al., 2001a), heparin at a
concentration of 10 g/ml inhibited more than 90% of
[3H]-thymidine labeled HHV-8 binding to the HFF cellsHHV-8 gB Specifically Binds to the 3 and 1
(Figure 6B). In contrast, RGD peptides, RGDgB-N1 anti-Chains of Integrin
bodies, anti-integrin antibodies, and soluble 31 integ-The role of RGD-containing HHV-8 gB in the interaction
rin at the concentrations used in the virus neutralizationwith 31 integrin was next examined. HHV-8 binds to
assays as well as at higher concentrations did not inhibitHS on the target cell surface (Akula et al., 2001b). Since
HHV-8 binding to the target cells (Figure 6B). Theseit was not clear whether HS would compete with the
results implicate a role for 31 integrin in the entry ofHHV-8 binding to integrins, heparinase I/III-treated or
HHV-8 into the target cells.-untreated HFF cells surface-labeled with biotin were
used in immunoprecipitation reactions. Since the cell
HHV-8 Activates the Integrin-Dependent Focalsurfaces were biotinylated, the cell surface locations of
Adhesion Kinase in the Target Cellsthe resolved integrin bands were confirmed in parallel
After the interaction with ligands, integrins, numerousexperiments by reacting the blots with alkaline phospha-
signaling molecules including FAK, C-Src, and p130cas,tase-labeled streptavidin (data not shown). The 1 integ-
and cytoskeletal proteins like talin, paxillin, vinculin, andrin was selected as a control since 96%, 99%, and 99%
 actin assemble into aggregates on each side of theof HFF cells expressed 1, 3, and 1 integrins, respec-
membrane called focal adhesions (FAs) (Giancotti andtively, with a relatively similar concentration of expres-
Ruoslahti, 1999). FAK is a nonreceptor protein-tyrosinesion (Figure 4E). Western-blotted purified 31 and
kinase that localizes with vinculin at the FAs, and FAK
11 integrins reacted with anti-1, -3, and -1 integrin
activation is the first step necessary for the outside-inantibodies served as markers for identifying the integrin
signaling by integrins (Sastry and Burridge, 2000). To
molecules (data not shown).
examine the potential mechanism of 31 integrin’s
From the heparinase I/III-treated cell-virus interaction
contribution in HHV-8 entry, FAK activation in HFF and
mixture, anti-gB antibodies specifically immunoprecipi-
HMVEC-d cells immediately after HHV-8 infection was
tated a 150/110 kDa heterodimer protein, which was analyzed.
identified as 3 and 1, respectively, by the 3 and 1 The distributions of FAK and vinculin in serum-starved
integrin chain-specific antibodies (Figure 6A, lanes 7 (data not shown) and mock-infected cells (Figure 7A)
and 8). The 1 chain of the integrin molecule was not were more diffused throughout the cytoplasm and inde-
immunoprecipitated by the anti-gB antibodies (Figure pendent of each other. In contrast, distinct patchy pat-
6A, lane 6). In the absence of virus, integrin antibodies terns of FAK and vinculin distribution was observed in
to 1 (Figure 6A, lane 2), 3 (Figure 6A, lane 3), and 1 HHV-8-infected cells, and a representative example
(Figure 6A, lane 4) did not react with any immunoprecipi- after 5 min infection is shown in Figure 7A. Image over-
tated proteins, thus confirming the specificity of these lays demonstrated the colocalization of FAK with vin-
virus-integrin interactions. HHV-8 also bound to 3 (Fig- culin, indicating the specificity of the altered FAK distri-
ure 6A, lane 10) and 1 (Figure 6A, lane 11), but not to bution in the infected cells. These patterns of FAK
1 (Figure 6A, lane 9) chain of integrin molecule from colocalization with vinculin were readily observed as
the heparinase I/III-untreated HFF cell lysate. The 3 early as 5 min after infection, and was comparable to
and 1 integrins were immunoprecipitated only by the the patterns observed in 20 ng/ml of lysophosphatidic
mouse anti-gB antibodies. MAbs to gpK8.1A (Zhu et al., acid (LPA)-treated cells (Figure 7A). Even though similar
1999) did not immunoprecipitate the 1 (Figure 6A, lane activation and redistribution of FAK were noticed in
12), 3 (Figure 6A, lane 13), or 1 (Figure 6A, lane 14) HMVEC-d cells, the basal level of FAK activity in the
chains of integrins. Mouse preimmune antibodies also quiescent HMVEC-d cells was much higher than the
did not precipitate the 1 integrin subunit (Figure 6A, HFF cells (data not shown). Nevertheless, these results
lane 5). These results demonstrated the loss of enve- demonstrated the activation of FAK during the early
loped virus integrity in the lysis buffer and confirmed stage of HHV-8 infection, presumably by its interaction
the specificity of HHV-8 gB interactions with 3 and 1 with integrins.
integrins. Taken together, these studies demonstrate a
direct role of HHV-8 gB in the interaction with 3 and HHV-8 Induces the Phosphorylation of FAK
1 chains of integrin molecules. Immunoprecipitation of in the Target Cells
1 integrin subunit only with 3 subunit, but not with 1 Tyr397 of FAK has been shown to specifically undergo
subunit, suggests that HHV-8 gB probably recognizes a autophosphorylation in response to integrin-ligand in-
teractions at the FA sites (McLean et al., 2000). Inductionspecific conformation of 31 heterodimers.
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Figure 6. HHV-8 gB Binds to the 31 Integrin
(A) Interaction of HHV-8 gB with 31 integrin molecules. Heparinase I/III-treated and -untreated HFF cell surfaces were biotinylated, solubilized,
precleared with preimmune mouse IgG antibodies, and mixed with purified HHV-8 at RT for 1 hr. These were immunoprecipitated with
preimmune mouse IgG antibodies (lane 5) or mouse anti-gB IgG antibodies (lanes 2–4 and 6–11) or MAb to gpK8.1A (lanes 12–14). Samples
were resolved in SDS-7.5% PAGE and were Western blotted. Membrane strips were probed with rabbit polyclonal antibodies to 1 (lanes 2,
6, 9, and 12), 3 (lanes 3, 7, 10, and 13), or 1 (lanes 4, 5, 8, 11, and 14) integrin subunits. Lane 1: Biotinylated HFF lysate probed with AP-
conjugated streptavidin and substrate. The numbers on the left indicate the molecular masses (in kDa) of the standard molecular weight
markers run in parallel lanes. The 3 and 1 integrins recognized by the antibodies are indicated on the right.
(B) HHV-8 interacts with 31 integrin at a postattachment step of infection. HFF cells were incubated with RGD, GRGDTP, and GRGESP
peptides and anti-integrin antibodies at 4C for 90 min and incubated with [3H]-thymidine labeled, purified HHV-8 (2,684 cpm). Labeled HHV-8
was also mixed with 10 g/ml of heparin or rabbit anti-RGD-gB-N1 antibodies or soluble integrins for 90 min at 4C and then added to the
cells. After incubation for 90 min at 4C with the virus, cells were washed, lysed, precipitated with TCA, and counted. The cell-associated
virus cpm in the presence of different treatment was calculated as the percentage inhibition of virus binding. Results with 15 mM of RGD,
GRGDTP, and GRGESP peptides, 20 g/ml of anti-integrin antibodies, 1 mg/ml of anti-RGD-gB-N1 antibodies, and 10 g/ml of soluble
integrins are shown here. In the absence of peptides and antibodies, approximately 21% of the input HHV-8 radioactivity became associated
with the cells. Each reaction was done in triplicate, and each point represents the average  the SD of three experiments.
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of cells for 5 min with 100 ng/ml of LPA resulted in about of HHV-8. Inhibition of more than 75% of HHV-8 infec-
tivity by RGD peptides and by the RGD-dependent solu-90% increase in FAK phosphorylation over the control
cells (Figure 7B, lanes 1 and 2). HHV-8 infection also ble 31 integrin suggest an RGD-dependent HHV-8
interactions with host cells. Absence of complete inhibi-rapidly induced the phosphorylation of FAK, with about
20% increase in FAK phosphorylation as early as 5 min tion of infection by the anti-31 antibodies and greater
but not complete inhibition by the soluble31 suggestspostinfection over control cells (Figure 7B, lane 3) and
with about 75% increase at 15 and 30 min postinfection that 31 integrin is not the only virus entry receptor in
the cells under study. The inability of antibodies to other(Figure 7B, lanes 4 and 5). The lowering of FAK phos-
phorylation to undetectable levels by treating infected RGD-dependent and -independent integrins with 1
subunit to block HHV-8 infectivity suggests that HHV-8cell lysates with tyrosine phosphatase 1B (Figure 7B,
lane 6) showed the specificity of anti-phospho-FAK anti- interacts with the specific combined conformation of
31 heterodimers, which is also supported by the im-bodies. Infection of HFF cells with herpes simplex virus
type-2 (HSV-2), shown to interact with HS and other munoprecipitation of 1 integrin subunit along with the
3 subunit, but not with the 1 subunit from the virus-nonintegrin cell surface molecules (Spear et al., 2000),
did not induce any significant levels of FAK phosphoryla- target cell mixture. The ability of integrin antibodies to
inhibit HHV-8 infectivity to comparable levels in HFF andtion (Figure 7B, lane 7). Treatment of cells for 1 hr before
infection with a nontoxic dose (100 M) of genistein, a HMVEC-d cells suggest that 31 integrin is a common
receptor for HHV-8 infection of these cells. It is interest-tyrosine phosphorylation inhibitor, and during the 30 min
incubation with virus lowered the HHV-8-induced FAK ing to note that in vivo, 31 integrin is expressed abun-
dantly in endothelial cells, epithelial cells, kerationcytes,phosphorylation to levels comparable to the uninduced
cells (Figure 7B, lane 8). The levels of actin did not alter B cells, and monocytes (Wu et al., 1995; Plow et al.,
2000), the same target cells in which HHV-8 DNA andin these experiments (Figure 7B, bottom), and dimethyl-
sulfoxide used as a solvent for genistein did not alter transcripts have been detected (Schulz et al., 1998).
Several viruses utilize multiple receptors for bindingthe expression of FAK (data not shown). These results
further confirmed the activation of FAK during the early and entry into cells. For example, the  herpesviruses
utilize HS molecules for cell surface binding and otherstages of HHV-8 interactions with the host cells.
nonintegrin molecules for entry (Spear et al., 2000). Simi-
larly, HHV-8 utilizes HS molecules for cell surface bind-Soluble 31 Integrin Blocks the HHV-8-Induced
ing (Akula et al., 2001b), and the present study implicatesPhosphorylation of FAK
a role for 31 integrin in the entry of HHV-8 into theTo determine the role of HHV-8-31 integrin interaction
in the FAK activation, soluble 31 or 51 integrins target cells. Integrin 31 is the second of multiple in
were mixed with HHV-8 and incubated for 1 hr at 37C vitro HHV-8 receptors to be identified, and further stud-
before infecting HFF cells. Compared to FAK phosphor- ies are required to determine the in vivo roles of these
ylation at 30 min postinfection in the untreated HHV-8- receptors in HHV-8 infection. Even though HHV-8 gB
infected cells (Figure 7C, lane 1), 5, 2.5, and 1.25 g/ and gpK8.1A interact with the HS molecules (Akula et
ml concentrations of soluble 31 integrin lowered the al., 2001a; Wang et al., 2001), which one of these glyco-
HHV-8-mediated FAK phosphorylation by about 72%, proteins mediate binding to HS during infection has not
60%, and 20% (Figure 7C, lanes 2–4), respectively. Solu- been established. HHV-8 gB binds to 3 and 1 integrin
ble 51 integrin did not significantly alter the HHV-8- subunits to a comparable extent in heparinase I/III-
mediated FAK phosphorylation (Figure 7C, lane 5). treated or -untreated HFF cells. This could be due to
These results demonstrated a direct role of HHV-8-31 HHV-8 gB interaction with HS via the putative heparin
integrin interaction in the activation of FAK. binding domain (HBD 108–117 aa; Akula et al., 2001a),
not competing with the virus-31 interaction by the
Anti-HHV-8 gB Antibodies Block the HHV-8- RGD motif (27–29 aa), or it could be due to HHV-8 inter-
Induced Phosphorylation of FAK action with HS solely by gpK8.1A.
Compared to FAK phosphorylation at 30 min postinfec- Many members of  and  herpesviruses deliver their
tion in the untreated HHV-8-infected cells (Figure 7D, DNA-containing capsids into the cells by fusing the vi-
lane 1), 100, 50, and 25 g/ml concentrations of anti- rion envelope with the plasma membrane (Compton et
gB antibodies lowered the HHV-8-mediated FAK phos- al., 1992; Spear et al., 2000). In contrast, in a similar
phorylation by about 74%, 39%, and 10% (Figure 7D, manner to simian virus-40 (SV-40) (Anderson et al., 1996)
lanes 2–4), respectively. HHV-8-mediated FAK phos- and 1-Epstein-Barr virus (EBV) (Nemerow and Cooper,
phorylation was not affected by the rabbit preimmune 1984), the 2-HHV-8 enters via large endocytic vesicles
(Figure 7D, lane 5) and anti-ORF 73 antibodies (data not in the human B cell line, BJAB (Akula et al., 2001b), HFF,
shown), even at 100 g/ml concentrations. Together 293, and endothelial cells (unpublished data). The ability
with the data demonstrating HHV-8 gB binding to the of HHV-8 gB to interact with31 integrin and the subse-
cell surface 31 integrin (Figure 6A) and the inhibition quent FAK activation suggests that HHV-8 utilizes integ-
of FAK activation by soluble 31 integrin (Figure 7C), rin and the associated signaling pathways to enter the
these results demonstrate a direct role of HHV-8 gB- cells. Since activation of FAK, Src-family kinases, and
31 integrin interaction in the activation of FAK. integrin-linked kinases (ILK) is central to many para-
digms of outside-in signaling by integrins, actin assem-
Discussion bly, and endocytosis (Calderwood et al., 2000), activa-
tion of FAK may have an important role in HHV-8
infection. Preliminary studies with chemical inhibitorsOur studies implicate the 31 integrin as one of the in
vitro cellular receptors involved in the infectious process suggest that HHV-8 enters cells by endocytosis. Studies
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Figure 7. HHV-8 Activates the Integrin-Dependent Focal Adhesion Kinase
(A) Colocalization of p125FAK with vinculin after HHV-8 infection. Serum-starved HFF cells were mock infected, infected with GFP-HHV-8, or
stimulated with 20 ng/ml of LPA for 5 min at 37C. At the end of incubation, cells were fixed, permeabilized, and reacted with rabbit anti-
p125FAK antibodies and mouse MAb to vinculin followed by anti-rabbit-FITC and anti-mouse-TRITC antibodies. Stained cells were examined
under a fluorescence microscope with appropriate filters. The arrowheads denote representative areas of p125FAK-vinculin colocalization.
Magnification 1,000.
(B) HHV-8 induces phosphorylation of FAK. Serum-starved HFF cells were uninduced (lane 1); induced with 100 ng/ml of LPA for 5 min (lane
2); infected with GFP-HHV-8 for 5 min (lane 3), 15 min (lane 4), and 30 min (lane 5); infected with HSV-2 for 30 min (lane 7); or pretreated with
100 M genistein and then infected with GFP-HHV-8 in the presence of 100 M genistein for 30 min (lane 8). At different time points at 37C,
cells were lysed and equivalent amounts of lysates were subjected to SDS-PAGE, transferred to PVDF membranes, reacted with anti-phospho-
FAK antibodies, and developed using chemiluminescent reagents. After reactions, membranes were stripped and reprobed with MAb to actin.
The phosphotyrosine residue in FAK at 30 min post-HHV-8 infection was dephosphorylated by incubating the membranes with 0.5 units of
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Experimental Proceduresto further clarify the mechanism by which the FAK activa-
tion promotes HHV-8 entry and the role of clathirin and/
Cellsor caveolin in the formation of endocytic vesicles are in
HFF cells, 293 cells, HMVEC-d (CC-2543, Clonetics, Walkersville,
progress. MD), BJAB (HHV-8-negative human B cells), BCBL-1 (HHV-8-posi-
The discovery that HHV-8 exploits 31 integrin for tive and EBV-negative human B cells), BCBL-1 cells harboring re-
combinant green fluorescence-HHV-8 (GFP-HHV-8; a gift from Dr.entry into the target cells may have important implica-
Jeffrey Vieira, Seattle), CHO-B2 cells transfected with pCDNA3tions in the unique biology of KS lesions and HHV-8’s
(CHO-B2/pCDNA3), and pCDNA3 containing human 3 integrinrole in the pathogenesis of KS. HIV-Tat protein is be-
cDNA (CHO-B2-clones B3 and D5; gifts from Dr. John A. McDonald,lieved to mimic the ECM molecules by interacting with
Scottsdale) were grown as per specifications described before (Wu
HS and with 51 and V3 integrins via its RGD se- et al., 1995; Akula et al., 2001a).
quence (Barillari et al., 1999). These interactions are
believed to displace the basic fibroblast growth factor Virus
BCBL-1 and GFP-BCBL-1 cells were stimulated with 20 ng/ml of(BFGF) from the ECM, increase the production of cyto-
TPA (Sigma, St.Louis, MO) for 6 days. Unlabeled wild-type HHV-8,kines and BFGF, and thus facilitate KS development.
GFP-HHV-8, and [3H]-thymidine labeled HHV-8 in the spent cultureEven though HIV infection accelerates KS development,
medium was concentrated and gradient purified using nycodenz
this may not be the sole inciting event in KS etiology, (Sigma), as described previously (Akula et al., 2001b).
since KS also occurs in the absence of HIV-1 infection.
In contrast, HHV-8 is present in all forms of KS (Antman Ligands, Peptides, and Integrins
Collagen type I, fibronectin, laminin, tenascin, vitronectin, GRGDTP,and Chang, 2000), has the RGD motif in the gB ORF,
and GRGESP peptides were obtained from GIBCO-BRL (Grand Is-and binds to HS and the 31 integrin molecule.
land, NY). Bovine serum albumin (BSA), chondroitin sulfate A andWhether HHV-8 binding to integrin and HS mediates
C, and the RGD peptide were obtained from Sigma. Soluble purified
similar biological effects that facilitate KS development, human integrins 31, 51, and 11 were obtained from Chemi-
as proposed for HIV-1 Tat, needs to be examined further. con International, Temecula, CA.
The cells cultured from KS tumors grow for a limited
Anti-Integrin Antibodiesnumber of passages, contain a mixture of cell types,
Function-blocking monoclonal antibodies (MAbs) against integrinsdepend upon growth factors, fail to grow in soft agar,
FB12 (anti-1, IgG1), ASC-6 (anti-3, IgG1), NKI-GoH3 (anti-6,and do not induce tumors in immunodeficient mice (Ga-
IgG2a), P3G8 (anti-V, IgG1), 6S6 (anti-1, IgG1), 2058Z (anti-4,
nem, 1998). The dominant cultured cell types are fibro- IgG1), BHA2.1 (anti-21, IgG1), JBS5 (anti-51, IgG1), LM609
blasts and endothelial cells, both of which have a spindle (anti-V3, IgG1), P1F6 (anti-V5, IgG1), 10D5 (anti-V6, IgG2a),
and rabbit polyclonal antibodies against integrins 1 (AB1934), 3shape. The factors driving the KS tumor spindle cell
(AB1920), and 1 (AB1952) obtained from Chemicon Internationalgrowth, the inability of KS cells latently infected with
were used in this study.HHV-8 to grow in cell culture, and the reason for the
loss of HHV-8 DNA within a few passages of KS cells
Anti-gB Antibodies
are not known. Evidences such as the reduced risk of The production and characterization of rabbit and mouse polyclonal
KS by ganciclovir treatment that can inhibit HHV-8 repli- antibodies against the baculovirus-expressed purified full-length
GST-gB fusion protein have been previously described (Akula et al.,cation (Antman and Chang, 2000) and increased anti-
2001a). Rabbits were immunized with the gB peptides RGDgB-N1bodies against lytic cycle proteins in KS patients (Zhu
(aa 27–44; RGDTFQTSSSPTPPGSSS), gB-N2 (aa 167–191; GVENet al., 1999; Antman and Chang, 2000) suggest a role
TFTDRDDVNTTVFLQPVEGLT), and gB-C (aa 828–845; RGYKPLTQfor HHV-8 lytic replication in KS. Lytic replication is an
SLDISPETGE) predicted to have antigenic regions with and without
obvious necessary precondition to KS lesion formation, the RGD sequence. IgG fractions were purified by Protein-A Sepha-
as it is required to generate progeny virions that can rose 4B columns (Amersham Pharmacia Biotech, Piscataway, NJ).
Nonspecific antibodies were removed by columns of cyanogen bro-target endothelial cells for latent infection. In addition
mide-activated Sepharose 4B covalently coupled with purified GSTto the delivery of viral nucleic acid into the cells, HHV-8
protein and BJAB cell lysate.interaction with integrins may also have other import-
ant biological consequences. Our studies indicate that Inhibition of GFP-HHV-8 Infectivity
HHV-8 interaction with host cell integrins and the associ- GFP-HHV-8 (100 l) was incubated at 37C for 1 hr with 100 l of
ated cell signaling pathways play a critical role in the DMEM alone or with DMEM containing different concentrations of
anti-gB antibodies or with soluble integrins. This mixture was addedinfectious process. Further studies are needed to exam-
to cells in 8-well chamber slides, incubated at 37C for 2 hr, washed,ine the consequences of such interactions with latently
and incubated at 37C for 3 days. Target cells were also incubatedinfected target cells and to discover whether such inter-
with different concentrations of ECM proteins, RGD peptides, or
actions play a role in the establishment and/or mainte- anti-integrin antibodies at 4C for 1 hr, washed, incubated with 100
nance of latent infection and/or in cellular proliferation l of GFP-HHV-8 at 37C for 2 hr, washed, and incubated at 37C
for 3 days. After 3 days, green fluorescent cells were examinedof latently infected cells.
protein tyrosine phosphatase 1B for 3 hr at 30C before reacting with anti-FAK antibodies (lane 6). The bands were scanned and the band
intensities were assessed using the ImageQuaNT software program (Molecular Dynamics).
(C) Soluble 31 integrin inhibits HHV-8-induced FAK phosphorylation. Serum-starved HFF cells were infected with GFP-HHV-8 (lane 1); with
GFP-HHV-8 preincubated with 5 g/ml (lane 2), 2.5 g/ml (lane 3), or 1.25 g/ml (lane 4) of 31 integrin; or with 5 g/ml of 51 integrin
(lane 5) at 37C for 1 hr before infecting cells. At 30 min postinfection, phosphorylation of FAK was measured as described in (B).
(D) Anti-gB antibodies block the HHV-8-induced FAK phosphorylation. HFF cells were infected with GFP-HHV-8 (lane 1); with GFP-HHV-8
preincubated with 100 g/ml (lane 2), 50 g/ml (lane 3), or 25 g/ml (lane 4) of anti-gB IgG antibodies; or with 100 g/ml of preimmune IgG
antibodies (lane 5) at 37C for 1 hr before infecting cells. At 30 min postinfection, phosphorylation of FAK was measured as described in (B).
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under a fluorescence microscope and were counted using the Nikon GFP-HHV-8 for 5, 15, and 30 min at 37C. HFF cells were also
preteated with 100 M of genistein for 1 hr at 37C and infectedMagna Firewire digital imaging system (Akula et al., 2001a).
with GFP-HHV-8 for 30 min at 37C in the presence of 100 M
genistein. At different time points, cells were washed in PBS andImmunoperoxidase Staining
lysed in NET lysis buffer, and protein concentrations were deter-After examining for GFP expression, cells were fixed with acetone
mined (Shaw et al., 2000). Equal amounts (4 g) of protein wereand incubated with MAb to HHV-8 ORF73 protein (ABI, Rockville,
resolved by SDS-7.5% PAGE, blotted onto a PVDF membrane (Milli-MD) for 30 min at 37C. Slides were washed and incubated with
pore, Bedford, MA), blocked in blocking buffer overnight at 4C,biotinylated anti-mouse antibodies (Vector Laboratories, Burlin-
reacted with anti-phospho-FAK antibodies (Y397, BD Transductiongame, CA) for 30 min at 37C, followed by treatment with Vectastain
Laboratories, Los Angeles, CA) for 3 hr at RT followed by HRP-ABC reagent and 3,3	-diaminobenzidine substrate.
conjugated goat anti-mouse antibodies for 90 min at RT, and devel-
oped using chemiluminescent reagent (NEN Life Science, Boston,Blocking HHV-8 Binding
MA). Membranes were stripped and reprobed with MAb to actinCells were incubated with different concentrations of RGD peptides
(clone AC-40; Sigma). The phosphotyrosine residue in FAK wasor anti-integrin antibodies in DMEM at 4C for 90 min, followed by
dephosphorylated by incubating the cell lysate with 0.5 units ofthe addition of a fixed quantity of [3H]-thymidine labeled purified
protein tyrosine phosphatase 1B (Calbiochem) for 3 hr at 30C beforeHHV-8 (2,684 cpm) (Akula et al., 2001b). Labeled HHV-8 was also
testing with anti-FAK antibodies. In other experiments, different con-incubated with different concentrations of rabbit anti-RGD-gB-N1
centrations of soluble integrins (31 or 51) or antibodies (anti-peptide antibodies or soluble 31 and 51 integrins or with 10
gB or anti-ORF 73 or preimmune IgGs) were mixed with GFP-HHV-8g/ml of heparin for 90 min at 4C before adding to the cells. After
and incubated for 1 hr at 37C before infecting HFF cells. After 30incubation for 90 min at 4C with the virus, cells were washed five
min at 37C, infected cells were lysed and FAK phosphorylation wastimes, lysed with 1% SDS and 1% Triton X-100, radioactivity precipi-
measured as described above.tated with trichloroacetic acid (TCA), and counted.
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